Please Wait.....
Report
Global Clinical Trials Support Services Market Forecast 2022-2030
Market Report I 2022-09-01 I 230 Pages I Inkwood Research
KEY FINDINGS
The global clinical trials support services market is estimated to boost with a 7.65% CAGR during the assessment period, 2022-2030. The market growth is driven by the rising prevalence of chronic disease & virus outbreaks and various benefits of clinical trial support services.
MARKET INSIGHTS
Clinical trials are controlled studies on humans to ensure the efficacy of drugs, food, and other product. These clinical trials are designed to satisfy the requirements of an agency related to product approvals and other human studies used in developing a product. Experiments and tests are performed on people and animals, and later the researchers or the investigators examine the outcomes
Further, support services make the clinical trial process easier. There are various key drivers for the growth of the studied market: the rise in the number of diseases and overcoming the challenges in clinical trials. The rising health problems and diseases have increased the clinical trials of new vaccines for new viruses and new and efficient drugs for the existing problems.
REGIONAL INSIGHTS
The global clinical trials support services market growth evaluation includes a thorough analysis of Europe, North America, Asia-Pacific, and Rest of World. North America is expected to capture around 38.27% market share by 2030 due to the presence of numerous leading industry players and advanced clinical studies in the region.
COMPETITIVE INSIGHTS
The competition is very high among the companies since the global clinical trials support services market is consolidated. Also, there are entry barriers for new entrants because of the presence of influential market leaders.
Some of the key market players include ICON PLC, IQVIA, Parexel, PSI CRO, KCR, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
3.1.2. BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
3.2. KEY RESTRAINTS
3.2.1. AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
3.2.2. STRINGENT REGULATIONS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
4.7.1. PERFORMANCE
4.7.2. EASE OF USE
4.7.3. SECURITY
4.7.4. COST-EFFECTIVENESS
4.8. REGULATORY FRAMEWORK
5. MARKET BY PHASE
5.1. PHASE I
5.2. PHASE II
5.3. PHASE III
5.4. PHASE IV
6. MARKET BY SPONSOR
6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
6.2. MEDICAL DEVICE COMPANIES
6.3. OTHER SPONSORS
7. MARKET BY SERVICE
7.1. CLINICAL TRIAL SITE MANAGEMENT
7.2. ADMINISTRATIVE STAFF
7.3. PATIENT RECRUITMENT MANAGEMENT
7.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
7.3.2. PATIENT RETENTION
7.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
7.4. IRB
7.5. DATA MANAGEMENT
7.6. OTHER SERVICES
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. KEY GROWTH ENABLERS
8.2.3. KEY CHALLENGES
8.2.4. KEY PLAYERS
8.2.5. COUNTRY ANALYSIS
8.2.5.1. UNITED KINGDOM
8.2.5.2. GERMANY
8.2.5.3. FRANCE
8.2.5.4. SPAIN
8.2.5.5. ITALY
8.2.5.6. SWEDEN
8.2.5.7. DENMARK
8.2.5.8. HUNGARY
8.2.5.9. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. KEY GROWTH ENABLERS
8.3.3. KEY CHALLENGES
8.3.4. KEY PLAYERS
8.3.5. COUNTRY ANALYSIS
8.3.5.1. CHINA
8.3.5.2. JAPAN
8.3.5.3. INDIA
8.3.5.4. SOUTH KOREA
8.3.5.5. TAIWAN
8.3.5.6. SINGAPORE
8.3.5.7. THAILAND
8.3.5.8. AUSTRALIA & NEW ZEALAND
8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. KEY GROWTH ENABLERS
8.4.3. KEY CHALLENGES
8.4.4. KEY PLAYERS
8.4.5. COUNTRY ANALYSIS
8.4.5.1. LATIN AMERICA
8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ADVANCED CLINICAL
9.2.2. ALCURA
9.2.3. CHARLES RIVER LABORATORIES INC
9.2.4. CLINIPACE
9.2.5. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
9.2.6. ICON PLC
9.2.7. IQVIA
9.2.8. KCR
9.2.9. LABCORP DRUG DEVELOPMENT
9.2.10. MEDPACE
9.2.11. PAREXEL
9.2.12. PSI CRO
9.2.13. SYNEOS HEALTH
9.2.14. WORLDWIDE CLINICAL TRIALS
9.2.15. WUXI APPTEC
TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: GLOBAL PHASE I MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: GLOBAL PHASE I MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: GLOBAL PHASE II MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: GLOBAL PHASE II MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: GLOBAL PHASE III MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: GLOBAL PHASE III MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: GLOBAL PHASE IV MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: GLOBAL PHASE IV MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 20: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 21: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 22: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 23: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 24: GLOBAL OTHER SPONSORS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 25: GLOBAL OTHER SPONSORS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 27: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 28: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 29: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 30: GLOBAL ADMINISTRATIVE STAFF MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 31: GLOBAL ADMINISTRATIVE STAFF MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 32: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 33: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 34: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 35: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 36: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 37: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 38: GLOBAL PATIENT RETENTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 39: GLOBAL PATIENT RETENTION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 40: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 41: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 42: GLOBAL IRB MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 43: GLOBAL IRB MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 44: GLOBAL DATA MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 45: GLOBAL DATA MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 46: GLOBAL OTHER SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 47: GLOBAL OTHER SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 48: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 49: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 50: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 51: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 52: LEADING PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 53: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 54: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 55: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 56: LEADING PLAYERS OPERATING IN EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 57: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 58: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 59: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 60: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 61: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 62: LEADING PLAYERS OPERATING IN REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 63: LIST OF MERGERS & ACQUISITIONS
TABLE 64: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 65: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 66: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2030 (IN $ MILLION)
FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 21: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 22: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
FIGURE 23: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 24: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2030 (IN $ MILLION)
FIGURE 25: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 27: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 28: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 31: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: SWEDEN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: DENMARK CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: HUNGARY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 41: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: TAIWAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: SINGAPORE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: THAILAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 48: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 49: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 50: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 51: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 52: MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security